T

TRIO Pharmaceuticals, Inc.

9 employees

Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Health Care

Date founded

2018

Funding rounds raised

Total raised

$2.2M

from 2 investors over 2 rounds

T

TRIO Pharmaceuticals, Inc. raised $2.2M on March 28, 2023

Investors: SeedFolio and -

FAQ